ICON has published our 2021 ESG report, which shows the strong progress we have made against our ESG priorities and commitments.
In 2021, one of the important ESG actions we took was to survey our key stakeholders, including our employees, customers and investors, on our ESG plans and get their views on where we can deliver positive impacts. The feedback we received has been incorporated into our 2021 report, and will also be an important input as we move forward with our ESG strategy and programs of activity.
Overall, the report shows our strong progress in 2021 under each element of ESG:
- Environmental – solid progress towards our reduction targets in electricity usage and emissions. ICON’s efficient use of office space and support for flexible working have been key.
- Social – ICON worked hard on its goal of advancing public health, as evidenced by the significant role we played in the fight against COVID-19. In particular, ICON worked with Pfizer and BioNTech on their vaccine - the first to get regulatory approval. ICON’s work also contributed to many other drug approvals, which are having a positive impact on patients’ health and lives. Diversity, inclusion and belonging continued as a key focus for ICON in 2021. Numerous initiatives that are focused on our employees and also on attracting increasingly diverse patient populations to participate in clinical trials are outlined in the report.
- Governance - as a publicly listed company, ICON remained focused on strong governance in 2021 and continues to do so.
At ICON, we work to improve the lives of patients by accelerating the development of our customers’ drugs and devices through innovative solutions. It is our people and their commitment – across our business and the world – that enable us to achieve this. Our employees are responsible for the examples of our ESG impact in this report. They continue to provide the commitment, talent, and initiative that drive our ESG program. ICON’s positive mission and our outstanding employees will allow us to make further progress our ESG journey in 2022 and beyond.